Introduction {#Sec1}
============

Quinoxaline and its derivatives show a broad spectrum of biological activities including anti-tumor \[[@CR1]\], anti-viral \[[@CR2]\], anti-tuberculosis \[[@CR3]\], and anti-inflammatory \[[@CR4]\] activities, and, hence, are an important class of nitrogen-containing heterocycles, and useful intermediates in organic synthesis \[[@CR5]\]. Furthermore, triazolo\[4,3-*a*\]quinoxalines have been shown to be potent and selective adenosine receptor ligands \[[@CR6]\].

The Sonogashira reaction catalyzed by palladium and copper is a powerful and straightforward method for the construction of arylated internal alkyne compounds \[[@CR7]--[@CR9]\]. These are important intermediates in organic synthesis and for the preparation of natural products \[[@CR10]\], biologically active molecules \[[@CR11]\], molecular electronics \[[@CR12]\], and polymers \[[@CR13]\].

Typically, these coupling-cyclization reactions are carried out using a palladium catalyst \[e.g., Pd(PPh~3~)~4~, (PPh~3~)~2~PdCl~2~, etc.\] and a copper salt as the co-catalyst in the presence of an amine base. The use of palladium on charcoal as a catalytic system for the efficient Sonogashira coupling of aryl halides with terminal alkynes has also been reported \[[@CR14]--[@CR17]\]. Compared to the frequently used expensive palladium catalysts \[e.g., Pd(PPh~3~)~4~, (PPh~3~)~2~PdCl~2~, etc.\], Pd/C-based methods have an economic advantage, and, hence, remain attractive for large or industrial scale preparations.

In recent years, a variety of modifications have been reported for this reaction, and significant progress has been made \[[@CR18]--[@CR22]\]. The most important modification is the elimination of the copper salt \[[@CR23]--[@CR27]\] since it can induce Glaser-type homocoupling of terminal alkynes in the presence of oxidants or air \[[@CR28]--[@CR30]\]. One of the powerful tools used to combine economic aspects with the environmental concerns is performing organic reactions in water; this strategy consists of two or more synthetic steps, which are carried out in water as a cheap, nontoxic, and environmentally friendly solvent, in a one-step reaction, without isolation of any intermediate, thus reducing time, and saving money, energy, and raw materials \[[@CR31]--[@CR33]\]. Several examples of Pd-catalyzed Sonogashira reactions in aqueous media have been reported \[[@CR34]--[@CR37]\].

Recently, our group has prepared pyrrolo\[2,3-*b*\]quinoxaline derivatives under mild conditions in one-pot reactions catalyzed by Pd--Cu \[[@CR38]--[@CR40]\]. We attempted to make this overall approach more attractive synthetically by examining the preparation of triazolo\[4,3-*a*\]quinoxalines using a one-pot reaction of 2,3-dichloroquinoxaline, hydrazine, aldehydes, bromine, and phenylacetylene catalyzed by Pd/C without the use of copper as a co-catalyst in water.

Results and discussion {#Sec2}
======================

We reported the synthesis of new derivatives of triazolo\[4,3-*a*\]quinoxalines via 10 % palladium/charcoal activated (Merck catalyst) catalyzed one-pot reaction of 2,3-dichloroquinoxaline, hydrazine, a suitable aldehyde, bromine, and phenylacetylene at 70 °C by employing water as the reaction medium. The use of water as a reaction medium represents remarkable benefits since this green solvent is highly polar and, therefore, immiscible with most organic compounds; moreover, the water-soluble by-products reside, and separation of the organic materials is thus easy.

Retrosynthetic analysis indicated that the desired 1-aryl-4-(2-phenylethynyl)\[1,2,4\]triazolo\[4,3-*a*\]quinoxalines can also be synthesized from 2,3-dichloroquinoxaline, hydrazine, a suitable aldehyde, and phenylacetylene as the starting materials (Scheme 1).Scheme 1

For optimization of the reaction conditions, we studied the effect of various reaction parameters including the base, palladium catalyst, and temperature on the outcome of the copper-free reaction of 2,3-dichloroquinoxaline (1 equiv.) with hydrazine hydrate (2 equiv.), benzaldehyde (1 equiv.), bromine (1 equiv.), and phenylacetylene (1 equiv.) in the presence of 10 % Pd/C (5 mol %) and K~2~CO~3~ (2 equiv.) in water at 70 °C (Table [1](#Tab1){ref-type="table"}).Table 1Effect of base and catalyst on the heterocyclization during the reaction of 2,3-dichloroquinoxaline (**1**) with hydrazine hydrate, bromine, benzaldehyde, and phenylacetylene^a^ ![](706_2012_904_Figb_HTML.gif){#d30e387}EntryCatalyst/mol%BaseYield/%^b^110 % Pd/C (5)Cs~2~CO~3~75210 % Pd/C (5)K~2~CO~3~82310 % Pd/C (5)KOH80410 % Pd/C (5)Na~2~CO~3~78510 % Pd/C (5)Et~3~N58610 % Pd/C (5)DIEA^c^42710 % Pd/C (5)Pyridine54810 % Pd/C (5)Piperidine609PdCl~2~ (5)/PPh~3~ (10)K~2~CO~3~5010PdCl~2~(PPh~3~)~2~ (5)K~2~CO~3~7011Pd(dba)~2~ (5)K~2~CO~3~7412PdCl~2~ (5)K~2~CO~3~451310 % Pd/C (3)K~2~CO~3~551410 % Pd/C (10)K~2~CO~3~8215^d^10 % Pd/C (5)K~2~CO~3~35^a^Reaction conditions: **1** (1.0 mmol), hydrazine hydrate (2.0 mmol), **2a** (1.0 mmol), bromine (1.0 mmol), phenylacetylene (1.0 mmol), K~2~CO~3~ (2.0 mmol), 70 °C, 12 h^b^Isolated yields^c^Diisopropylethylamine^d^Reaction at 25 °C

The reaction was influenced significantly by the base employed. It worked very well when inorganic bases such as K~2~CO~3~ and KOH were used (entries 2 and 3), with the best result obtained in the case of potassium carbonate. Two of the organic bases used, triethylamine and piperidine, also gave good yields (entries 5 and 8). It was found that while PdCl~2~(PPh~3~)~2~, PdCl~2~/PPh~3~, PdCl~2~, and Pd~2~(dba)~3~·CHCl~3~ all catalyzed the reaction without the aid of any surfactant (entries 9--12), 10 % Pd/C turned out to be the best catalyst in terms of yields (entry 2). When the catalyst loading was decreased to 3 mol %, the yield of **4a** was 55 % (entry 13). Increasing the amount of palladium catalyst did not increase the yield (entry 14). Decreasing the temperature to 25 °C caused the yield to decrease to 35 % (entry 15).

In order to examine the scope of this reaction, compound **1** was reacted with hydrazine, various aldehydes **2**, bromine, and phenylacetylene in water at 70 °C to triazolo\[4,3-*a*\]quinoxalines in moderate to good yields (Table [2](#Tab2){ref-type="table"}). When the less reactive acetylene, 1-hexyne, 1-octyne, and propargyl alcohol were used, Sonogashira coupling could not be achieved. The reactions were carried out under an argon atmosphere, and water was degassed prior to use.Table 2Synthesis of triazolo\[4,3-*a*\]quinoxalines **4a**--**4k** ^a^ ![](706_2012_904_Figc_HTML.gif){#d30e805}EntryArProductYield/%^b^1C~6~H~5~**4a**8222-NO~2~--C~6~H~4~**4b**9433-NO~2~--C~6~H~4~**4c**7444-NO~2~--C~6~H~4~**4d**9452-F--C~6~H~4~**4e**7664-F--C~6~H~4~**4f**8572-Cl--C~6~H~4~**4g**8384-Cl--C~6~H~4~**4h**8692,6-Cl~2~--C~6~H~3~**4i**75104-CH~3~--C~6~H~4~**4j**80114-CH~3~O--C~6~H~4~**4k**81^a^Reaction conditions: **1** (1.0 mmol), hydrazine hydrate (2.0 mmol), **2a**--**2k** (1.0 mmol), phenylacetylene (1.0 mmol), bromine (1.0 mmol), K~2~CO~3~ (2.0 mmol), 10 % Pd/C (5 mol %), 5 cm^3^ degassed water, 70 °C, 10 h^b^Isolated yields

Mechanistically, the formation of triazolo\[4,3-*a*\]quinoxalines **4** involves the following steps (Scheme 2): (i) formation of 1-aryl-4-chloro\[1,2,4\]triazolo\[4,3-*a*\]quinoxalines from the cyclization of intermediate **A** catalyzed by bromine \[[@CR41]\]; and (ii) Sonogashira coupling reaction of **3** with phenyl acetylene.Scheme 2

Conclusion {#Sec3}
==========

In conclusion, the chemistry outlined here provides a simple, efficient, clean, and straightforward method for the synthesis of triazolo\[4,3-*a*\]quinoxaline derivatives via the copper-free, Pd/C-catalyzed reaction of readily available dichloroquinoxaline with hydrazine, bromine, phenylacetylene, and a variety of aldehydes in water. This methodology does not involve the use of expensive reagents or catalysts, and thus permits a new and practical access to triazolo\[4,3-*a*\]quinoxalines.

Experimental {#Sec4}
============

All the compounds (phenylacetylene, aldehydes, Pd/C) were obtained from Merck. The reagents used were purchased from commercial suppliers, and used without further purification. Merck silica gel 60 was used for chromatography (230--400 mesh). The IR spectra were obtained as KBr pellets in the range of 400--4,000 cm^−1^ on a Shimadzu Model 460 spectrophotometer. ^1^H NMR spectra were recorded at 400 MHz, and ^13^C NMR spectra were recorded at 100 MHz in DMSO-*d*~*6*~. The chemical shifts are reported in ppm (*δ*), and referenced to the residual proton signal for DMSO-*d*~*6*~ (2.49 ppm). The coupling constants (*J*) are reported in Hz. Mass spectrometric data (MS) were obtained by electron ionization (EI, 70 eV) or electrospray ionization (ESI).

*Typical procedure for the synthesis of 1*-*aryl*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxalines****4a***--***4k*** {#Sec5987}
-------------------------------------------------------------------------------------------------------------------------------------

A mixture of 199 mg 2,3-dichloroquinoxaline (1.0 mmol), 0.1 cm^3^ hydrazine hydrate (99 %, 2.0 mmol), a suitable aldehyde (1.0 mmol), and 0.05 cm^3^ bromine (1.0 mmol) were stirred in 5 cm^3^ H~2~O at room temperature under an argon atmosphere for 30 min. Phenylacetylene (0.11 cm^3^, 1 mmol), 53 mg Pd/C (10 %, 0.05 mmol), and 276 mg K~2~CO~3~ (2.0 mmol) were added, and the resulting solution was heated at 70 °C for 12 h, and then cooled to room temperature. The reaction mixture was filtered, and the filtrate was concentrated in vacuo. The residue was purified by chromatography, eluting with CHCl~3~/CH~3~OH (98:2) to afford the pure product (Table [2](#Tab2){ref-type="table"}).

### *1*-*Phenyl*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4a**, C~23~H~14~N~4~) {#d30e1250}

White solid; yield 283 mg (82 %); m.p.: 280--282 °C; *R*~*f*~ = 0.53; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,200, 1,650 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.32--7.42 (m, 4H), 7.45--7.55 (m, 4H), 7.67 (d, *J* = 4.8 Hz, 1H), 7.81 (d, *J* = 4.1 Hz, 1H), 7.86--7.92 (m, 3H), 8.05--8.08 (m, 1H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.26, 96.37, 123.80, 127.55, 127.85, 128.11, 128.21, 128.70, 128.95, 129.22, 129.55, 129.76, 130.45, 132.10, 132.45, 138.92, 142.17, 145.11, 149.12 ppm; MS (EI, 70 eV): *m/z* (%) = 346 (\[M^+^\], 100), 269 (52), 245 (22), 167 (16); HRMS (ESI): *m/z* = 346.1201.

### *1*-*(2*-*Nitrophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4b**, C~23~H~13~N~5~O~2~) {#d30e1339}

White solid; yield 367 mg (94 %); m.p.: 284--286 °C; *R*~*f*~ = 0.55; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,200, 1,600, 1,540, 1,340 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.56--7.63 (m, 3H), 7.73--7.75 (m, 1H), 7.80--7.87 (m, 3H), 7.95 (dd, *J* = 6.4, 2.0 Hz, 2H), 8.05--8.10 (m, 2H), 8.16--8.19 (m, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.39, 96.45, 121.36, 122.72, 127.45, 128.25, 128.35, 128.47, 128.66, 129.42, 129.58, 129.68, 131.36, 132.45, 132.60, 135.54, 142.36, 145.78, 149.25 ppm; MS (EI, 70 eV): *m/z* (%) = 391 (\[M^+^\], 100), 345 (32), 314 (51), 290 (21), 169 (24); HRMS (ESI): *m/z* = 391.1037.

### *1*-*(3*-*Nitrophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4c**, C~23~H~13~N~5~O~2~) {#d30e1431}

White solid; yield 289 mg (74 %); m.p.: 274--276 °C; *R*~*f*~ = 0.52; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,230, 1,610, 1,530, 1,340 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.28 (s, 1H), 7.35--7.40 (m, 2H), 7.46--7.52 (m, 3H), 7.54--7.60 (m, 3H), 7.64--7.71 (m, 3H), 8.03--8.06 (m, 1H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.26, 96.35, 121.10, 122.45, 127.52, 128.45, 129.26, 129.45, 129.64, 129.88, 130.20, 131.36, 132.25, 132.45, 142.36, 145.56, 148.92, 149.55 ppm; MS (EI, 70 eV): *m/z* (%) = 391 (\[M^+^\], 100), 345 (35), 314 (43), 290 (26), 167 (21); HRMS (ESI): *m/z* = 391.1042.

### *1*-*(4*-*Nitrophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4d**, C~23~H~13~N~5~O~2~) {#d30e1520}

White solid; yield 367 mg (94 %); m.p.: 293--295 °C; *R*~*f*~ = 0.54; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,210, 1,620, 1,540, 1,320 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.40 (d, *J* = 8.4 Hz, 1H), 7.55--7.61 (m, 4H), 7.68--7.71 (m, 1H), 7.80--7.86 (m, 2H), 8.11--8.18 (m, 3H), 8.55 (d, *J* = 8.2 Hz, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 84.95, 96.35, 116.61, 120.60, 124.75, 126.02, 128.50, 129.68, 130.72, 131.29, 132.14, 132.85, 134.87, 135.97, 136.09, 145.33, 148.53, 149.46 ppm; MS (EI, 70 eV): *m/z* (%) = 391 (\[M^+^\], 100), 345 (40), 314 (47), 290 (18), 168 (29); HRMS (ESI): *m/z* = 391.1047.

### *1*-*(2*-*Fluorophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4e**, C~23~H~13~FN~4~) {#d30e1615}

White solid; yield 276 mg (76 %); m.p.: 305--307 °C; *R*~*f*~ = 0.50; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,250, 1,570 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.20 (s, 1H), 7.35--7.43 (m, 4H), 7.57--7.64 (m, 4H), 7.82--7.86 (m, 2H), 8.21 (d, *J* = 8.0 Hz, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.80, 96.42, 116.62, 122.26, 122.92, 124.85, 127.70, 128.37, 128.81, 129.21, 130.35, 130.56, 133.51, 133.65, 141.52, 146.23, 146.56, 149.55, 160.42 ppm; MS (EI, 70 eV): *m/z* (%) = 364 (\[M^+^\], 100), 345 (27), 287 (62), 263 (42), 167 (25); HRMS (ESI): *m/z* = 364.1152.

### *1*-*(4*-*Fluorophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4f**, C~23~H~13~FN~4~) {#d30e1704}

White solid; yield 309 mg (85 %); m.p.: 313--315 °C; *R*~*f*~ = 0.51; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,230, 1,590 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.20 (s, 1H), 7.35--7.41 (m, 2H), 7.55--7.62 (m, 2H), 7.78--7.82 (m, 2H), 7.90--7.98 (m, 4H), 8.15--8.19 (m, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.82, 96.44, 116.36, 116.45, 122.32, 126.22, 127.32, 128.24, 128.55, 128.74, 128.92, 129.20, 130.35, 130.47, 132.10, 132.21, 142.30, 145.25, 149.25, 162.92 ppm; MS (EI, 70 eV): *m/z* (%) = 364 (\[M^+^\], 100), 345 (32), 287 (67), 263 (35), 167 (29); HRMS (ESI): *m/z* = 364.1144.

### *1*-*(2*-*Chlorophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4g**, C~23~H~13~ClN~4~) {#d30e1790}

White solid; yield 315 mg (83 %); m.p.: 276--278 °C; *R*~*f*~ = 0.56; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,250, 1,600 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.35 (s, 1H), 7.43--7.52 (m, 4H), 7.60--7.70 (m, 4H), 8.06--8.12 (m, 2H), 8.40 (d, *J* = 8.0 Hz, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.65, 96.53, 123.42, 127.53, 127.65, 128.21, 128.32, 128.42, 128.65, 129.25, 129.64, 130.36, 130.54, 132.25, 132.36, 132.46, 138.65, 142.35, 145.65, 149.58 ppm; MS (EI, 70 eV): *m/z* (%) = 382 (\[M^+^\]\[^37^Cl\], 31), 380 (\[M^+^\]\[^35^Cl\], 100), 345 (35), 303 (57), 279 (21), 167 (25); HRMS (ESI): *m/z* = 380.0850.

### *1*-*(4*-*Chlorophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4h**, C~23~H~13~ClN~4~) {#d30e1889}

White solid; yield 326 mg (86 %); m.p.: 289--291 °C; *R*~*f*~ = 0.55; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,240, 1,600 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.41--7.45 (m, 1H), 7.55--7.63 (m, 4H), 7.65--7.69 (m, 1H), 7.71--7.77 (m, 3H), 7.85 (d, *J* = 8.0 Hz, 2H), 8.11--8.18 (m, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.01, 96.20, 116.25, 120.63, 126.18, 127.49, 128.34, 129.68, 129.85, 130.60, 131.27, 132.45, 132.83, 136.03, 136.46, 136.80, 145.11, 149.14 ppm; MS (EI, 70 eV): *m/z* (%) = 382 (\[M^+^\]\[^37^Cl\], 32), 380 (\[M^+^\]\[^35^Cl\], 100), 345 (30), 303 (62), 279 (26), 168 (20); HRMS (ESI): *m/z* = 380.0850.

### *1*-*(2,6*-*Dichlorophenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4i**, C~23~H~12~Cl~2~N~4~) {#d30e1988}

White solid; yield 310 mg (75 %); m.p.: 267--269 °C; *R*~*f*~ = 0.57; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,210, 1,620 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 7.20 (s, 1H), 7.40--7.48 (m, 4H), 7.55--7.62 (m, 3H), 7.75--7.78 (m, 2H), 8.12--8.15 (m, 1H), 8.17--8.20 (m, 1H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 85.35, 96.23, 127.80, 127.95, 128.44, 128.84, 128.92, 129.10, 129.25, 129.54, 130.92, 131.44, 132.35, 132.74, 133.55, 138.22, 142.62, 145.84, 149.12 ppm; MS (EI, 70 eV): *m/z* (%) = 418 (\[M^+^\]\[^37^Cl~2~\], 12), 416 (\[M^+^\]\[^37^Cl\]\[^35^Cl\], 53), 414 (\[M^+^\]\[^35^Cl~2~\], 100), 381 (23), 339 (65), 313 (30), 269 (32), 168 (15); HRMS (ESI): *m/z* = 414.0475.

### *1*-*(4*-*Methylphenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4j**, C~24~H~16~N~4~) {#d30e2103}

White solid; yield 288 mg (80 %); m.p.: 218--220 °C; *R*~*f*~ = 0.52; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,220, 1,600 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 2.39 (s, 3H), 7.36 (d, *J* = 8.0 Hz, 2H), 7.50--7.62 (m, 4H), 7.70--7.77 (m, 3H), 8.08--8.14 (m, 2H), 8.40--8.46 (m, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 22.62, 85.12, 96.21, 116.25, 120.53, 124.62, 126.10, 128.42, 128.60, 129.52, 129.92, 130.62, 132.34, 132.45, 138.40, 140.92, 141.52, 145.22, 149.62 ppm; MS (EI, 70 eV): *m/z* (%) = 360 (\[M^+^\], 100), 345 (21), 283 (64), 259 (24), 168 (22); HRMS (ESI): *m/z* = 360.1343.

### *1*-*(4*-*Methoxyphenyl)*-*4*-*(2*-*phenylethynyl)\[1,2,4\]triazolo\[4,3*-*a\]quinoxaline* (**4k**, C~24~H~16~N~4~O) {#d30e2192}

White solid; yield 304 mg (81 %); m.p.: 250--252 °C; *R*~*f*~ = 0.51; IR (KBr): $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 2,200, 1,620 cm^−1^; ^1^H NMR (400 MHz, DMSO-*d*~6~): *δ* = 3.90 (s, 3H), 7.20 (d, *J* = 8.7 Hz, 2H), 7.41--7.52 (m, 3H), 7.54--7.62 (m, 3H), 7.67--7.70 (m, 1H), 7.75--7.81 (m, 2H), 8.06 (d, *J* = 8.4 Hz, 2H) ppm; ^13^C NMR (100 MHz, DMSO-*d*~6~): *δ* = 55.92, 85.15, 96.20, 116.12, 122.36, 124.51, 126.15, 128.21, 128.42, 128.52, 128.95, 129.55, 129.78, 130.54, 132.32, 132.45, 140.48, 145.23, 149.65 ppm; MS (EI, 70 eV): *m/z* (%) = 376 (\[M^+^\], 100), 345 (21), 299 (64), 275 (27), 269 (32), 168 (27); HRMS (ESI): *m/z* = 376.1360.
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